We are live on ! Find out more
PLRX icon

Pliant Therapeutics
PLRX

135 hedge funds and large institutions have $971M invested in Pliant Therapeutics in 2024 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 47 increasing their positions, 36 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 36

13% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 16

2.84% more ownership

Funds ownership: 105.37% → 108.21% (+2.8%)

1% more funds holding

Funds holding: 134 → 135 (+1)

14% less call options, than puts

Call options by funds: $4.2M | Put options by funds: $4.91M

15% less capital invested

Capital invested by funds: $1.14B → $971M (-$172M)

29% less funds holding in top 10

Funds holding in top 10: 7 → 5 (-2)

Holders
135
Holders Change
+1
Holders Change %
+0.75%
% of All Funds
1.94%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.07%
New
18
Increased
47
Reduced
36
Closed
16
Calls
$4.2M
Puts
$4.91M
Net Calls
-$711K
Net Calls Change
+$3.1M

Top Buyers

1
Deutsche Bank
Deutsche Bank
Germany
+$8.26M
2
Capital International Investors
Capital International Investors
California
+$7.67M
3
Bank of America
Bank of America
North Carolina
+$6.92M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$6.8M
5
RG
Redmile Group
California
+$6.61M

Top Sellers

1
CC
Casdin Capital
New York
-$9.52M
2
Morgan Stanley
Morgan Stanley
New York
-$7.03M
3
BlackRock
BlackRock
New York
-$2.41M
4
SCM
Silverarc Capital Management
Massachusetts
-$2.23M
5
LCM
Laurion Capital Management
New York
-$1.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
DTC
1
Deep Track Capital
Connecticut
$85.7M – – –
BlackRock
2
BlackRock
New York
$69.4M -$2.41M -146,132 -3%
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$59M +$2.86M +173,172 +5%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$58.8M -$279K -16,921 -0.4%
FLAM
5
First Light Asset Management
Minnesota
$52.7M -$937K -56,783 -2%
Vanguard Group
6
Vanguard Group
Pennsylvania
$51.8M +$6.8M +412,486 +13%
LCM
7
Laurion Capital Management
New York
$51.8M -$1.8M -108,823 -3%
RG
8
Redmile Group
California
$46.1M +$6.61M +400,572 +15%
BOCH
9
Blue Owl Capital Holdings
New York
$44.8M – – –
TGI
10
TRV GP IV
Massachusetts
$31.8M – – –
PCH
11
Polar Capital Holdings
United Kingdom
$30M – – –
GPP
12
Great Point Partners
Connecticut
$27.6M +$473K +28,680 +2%
Citadel Advisors
13
Citadel Advisors
Florida
$25.4M +$2.03M +123,232 +8%
Franklin Resources
14
Franklin Resources
California
$22.9M -$705K -42,722 -3%
Deutsche Bank
15
Deutsche Bank
Germany
$22.1M +$8.26M +500,801 +51%
Capital International Investors
16
Capital International Investors
California
$20.5M +$7.67M +464,860 +51%
State Street
17
State Street
Massachusetts
$19.6M -$272K -16,511 -1%
Pictet Asset Management
18
Pictet Asset Management
Switzerland
$19.5M -$185K -11,193 -0.8%
RCM
19
RA Capital Management
Massachusetts
$19.1M – – –
Geode Capital Management
20
Geode Capital Management
Massachusetts
$18.1M +$457K +27,685 +2%
GIM
21
Granahan Investment Management
Massachusetts
$15.6M -$1.71M -103,921 -9%
CC
22
Casdin Capital
New York
$14.9M -$9.52M -577,108 -37%
CS
23
Candriam SCA
Luxembourg
$8.17M +$1.57M +95,000 +21%
Bessemer Group
24
Bessemer Group
New Jersey
$7.93M – – –
Goldman Sachs
25
Goldman Sachs
New York
$7.49M +$1.9M +115,325 +30%
1
2 3 4 5

PLRX Hedge Fund Activity: Q1 2024 in Review

135 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Pliant Therapeutics (PLRX) for Q1 2024, worth a combined $971M — down 15% from $1.14B a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new PLRX positions and 16 closed out — a net gain of 2 holders — while 47 added to existing stakes and 36 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $8.26M. The largest seller was Casdin Capital, cutting an estimated $9.52M.

  • 135 institutional investors held Pliant Therapeutics (PLRX) as of Q1 2024, up from 134 in Q4 2023.
  • Funds reported $971M of Pliant Therapeutics stock for Q1 2024, down 15% quarter-over-quarter.
  • 18 funds opened new Pliant Therapeutics positions in Q1 2024 and 16 closed out, a net change of +2 holders.
  • The largest Pliant Therapeutics buyer in Q1 2024 was Deutsche Bank, an estimated $8.26M added.
  • The largest Pliant Therapeutics seller in Q1 2024 was Casdin Capital, an estimated $9.52M sold.

Based on aggregated 13F filings for Q1 2024.